We are delighted to attend the 2nd Annual mRNA-Based Therapeutics Summit 24th-26th January 2023 in Berlin.
Following the successful development of vaccines against Covid-19, biopharma hopes to deploy mRNA-based therapies to combat many other diseases in oncology, rare disorders, and beyond. The meeting is an ideal opportunity for us to meet colleagues from across the entire mRNA spectrum.
The research in this area has made great strides in recent years, with mRNA technology providing efficient, non-toxic delivery and clear therapeutic effects for previously untargeted diseases.
We are looking forward to hearing the latest on mRNA vaccine developments, emerging therapeutic trajectories and much more.
You can find out more about the event here: